HF
MIRA icon

HRT Financial’s MIRA Pharmaceuticals MIRA Stock Holding History

HRT Financial’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
+13,450
New +$13.6K ﹤0.01% 3973
2024
Q2 		– Sell
-30,651
Closed -$33K – 2747
2024
Q1 		$33K Buy
+30,651
New +$33.3K ﹤0.01% 1973

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's MIRA Position: Q2 2026 in Review

HRT Financial opened a new position in MIRA Pharmaceuticals (MIRA) in Q2 2026: 13,450 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #3973 among its holdings. This is a return to the name: HRT Financial previously reported a position in MIRA as recently as Q1 2024.

HRT Financial first reported a position in MIRA in Q1 2024 and has held it in 2 quarters since. The position peaked at $33K in Q1 2024. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • HRT Financial held 13,450 shares of MIRA Pharmaceuticals worth $12K as of Q2 2026.
  • MIRA Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3973 holding.
  • HRT Financial first reported a position in MIRA Pharmaceuticals in Q1 2024 and has held it in 2 quarters since.
  • HRT Financial's MIRA Pharmaceuticals position peaked at $33K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.